This resilience is crucial for academic and commercial labs that require extended shelf life and repeatable performance across multiple test groups
Employers should stay informed about these regulatory changes to manage prescription drug costs and ensure employee medication access
A clinic that dismisses the peptide entirely on the basis of the failed Phase III is also overstating, in the other direction
There are many people who are against these drugs because of how they contribute to the idea that we can and should all be thin, she says theres a fear that this will contribute to more eating disorders, and that people will never be able to accept their bodies, theyll always be told: Well, you could be thinner, just use this medicine. For now, what clinicians can do is what most of them are already doing: screening patients for a history of eating disorders before prescribing GLP-1s
Michele Green
For proper injection technique that minimizes discomfort and anxiety-related sleep disruption, see our how to inject BPC-157 guide
